383 — Tian An Medicare Cashflow Statement
0.000.00%
- HK$846.02m
- HK$867.70m
- HK$1.63bn
- 61
- 72
- 38
- 62
Annual cashflow statement for Tian An Medicare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -96.6 | -110 | -117 | 35.4 | 57 |
Depreciation | |||||
Non-Cash Items | 119 | 170 | 141 | 40.8 | 67.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -154 | 55 | -57.9 | 182 | -115 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -15.2 | 219 | 70.4 | 356 | 106 |
Capital Expenditures | -100 | -154 | -138 | -198 | -193 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -22.8 | -30.6 | 39.3 | 19.2 | 58.3 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -123 | -185 | -98.6 | -179 | -135 |
Financing Cash Flow Items | 0 | — | -59 | -47.8 | -34.2 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 109 | -79.1 | 29.9 | 101 | 29.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -26.7 | -40 | 12.6 | 301 | -4.84 |